Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: Drug Dev Res. 1996 Sep 1;39(1):36–46. doi: 10.1002/(sici)1098-2299(19960901)39:1<36::aid-ddr5>3.0.co;2-l

TABLE 1.

Adenosine Analogs: Affinity for Rat Brain A3-Adenosine Receptors and EC50 Values for Stimulation of [3H]IP1 Formation and Elevation of Intracellular Calcium in a Rat RBL-2H3 Mast Cell Line

RBL-2H3 cells
Rat brain Stimulation Elevation of [Ca2+]i
Analoga A3-receptors
Ki (nM)b
[3H]IP1 EC50c
(µM)
EC50d
(µM)
Relative
efficacye
2-CI-IBMECA 0.33 4.1 ± 1 0.07 ± 0.04 60
IBMECA 1.1 8.5 ± 1.7 0.11 ± 0.00 55
CHNECA 16 12.2 ± 2.1 0.4 54
NECA 113 2.1 ± 0.3 1.37 ± 0.18 100
APNEA 116 7.5 ± 1.5 0.9 38
BZADO 120 12.7 ± 2.6 2.7 60
R-PIA 158 5.5 ± 0.9 2.4 38
CHA 167 11.6 ± 1.1 0.88 ± 0.00 30
CGS 21680 584 5.8 ± 0.6 0.79 ± 0.02 28
ADO ~1,000 11.8 ± 1.1 1.45 ± 0.25 72
2-CIADO 1890 8.1 ± 1.5 1.7 25
8-BrADO >100,000 13.9 ± 1.0 Inactive
a

Abbreviations in legend to Fig. 1.

c

EC50 values determined from data of Fig. 1A.

d

EC50 values determined from data such as that presented in Fig. 4. Values are means ± s.e.m. (n = 3) or are from single determinations.

e

Efficacies relative to NECA set equal to 100 estimated from data such as those presented in Fig. 4.